Another study profiled miRs in 215 newly diagnosed AML cases using reverse-transcription-polymerase chain reaction (RT-PCR-based) and identified unique miR expression patterns in AML patients with t(8;21), t(15;17), inv(16), NPM1, and CEBPA mutations (3). This evidence concerns the gene NPM1 and acute myeloid leukemia.